{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T11:50:28Z","timestamp":1657626628122},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T00:00:00Z","timestamp":1657497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T00:00:00Z","timestamp":1657497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Office of the Higher Education Commission of Thailand and Mahidol University","award":["NRU 2557"],"award-info":[{"award-number":["NRU 2557"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p><jats:italic>Plasmodium falciparum<\/jats:italic> has been becoming resistant to the currently used anti-malarial drugs. Searching for new drug targets is urgently needed for anti-malarial development. DNA helicases separating double-stranded DNA into single-stranded DNA intermediates are essential in nearly all DNA metabolic transactions, thus they may act as a candidate for new drug targets against malarial parasites.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, a <jats:italic>P. falciparum<\/jats:italic> 5\u2032 to 3\u2032 DNA helicase (PfDH-B) was partially purified from the crude extract of chloroquine- and pyrimethamine-resistant <jats:italic>P. falciparum<\/jats:italic> strain K1, by ammonium sulfate precipitation and three chromatographic procedures. DNA helicase activity of partially purified PfDH-B was examined by measuring its ability to unwind <jats:sup>32<\/jats:sup>P-labelled partial duplex DNA. The directionality of PfDH-B was determined, and substrate preference was tested by using various substrates. Inhibitory effects of DNA intercalators such as anthracycline antibiotics on PfDH-B unwinding activity and parasite growth were investigated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The native PfDH-B was partially purified with a specific activity of 4150 units\/mg. The PfDH-B could unwind M13-17-mer, M13-31-mer with hanging tail at 3\u2032 or 5\u2032 end and a linear substrate with 3\u2032 end hanging tail but not blunt-ended duplex DNA, and did not need a fork-like substrate. Anthracyclines including aclarubicin, daunorubicin, doxorubicin, and nogalamycin inhibited the unwinding activity of PfDH-B with an IC<jats:sub>50<\/jats:sub> value of 4.0, 7.5, 3.6, and 3.1\u00a0\u00b5M, respectively. Nogalamycin was the most effective inhibitor on PfDH-B unwinding activity and parasite growth (IC<jats:sub>50<\/jats:sub>\u2009=\u20090.1\u2009\u00b1\u20090.002\u00a0\u00b5M).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Partial purification and characterization of 5\u2032\u20133\u2032 DNA helicase\u00a0of\u00a0<jats:italic>P. falciparum<\/jats:italic>\u00a0was successfully performed. The partially purified PfDH-B does not need a fork-like substrate structure found in\u00a0<jats:italic>P. falciparum<\/jats:italic>\u00a03\u2032 to 5\u2032 DNA helicase (PfDH-A). Interestingly, nogalamycin was the most potent anthracycline inhibitor for PfDH-B helicase activity and parasite growth in culture. Further studies are needed to search for more potent but less cytotoxic inhibitors targeting <jats:italic>P. falciparum<\/jats:italic> DNA helicase in the future.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12936-022-04238-y","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T08:46:57Z","timestamp":1657615617000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inhibitory effects of anthracyclines on partially purified 5\u2032\u20133\u2032 DNA helicase of Plasmodium falciparum"],"prefix":"10.1186","volume":"21","author":[{"given":"Pongruj","family":"Rattaprasert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pattra","family":"Suntornthiticharoen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paviga","family":"Limudomporn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanthinich","family":"Thima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Porntip","family":"Chavalitshewinkoon-Petmitr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,11]]},"reference":[{"key":"4238_CR1","unstructured":"WHO. World Malaria Report 2021. Geneva: World Health Organization; 2021. https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2021. Accessed 25 Jan 2022."},{"key":"4238_CR2","volume-title":"DNA replication","author":"T Baker","year":"1991","unstructured":"Baker T, Kornberg A. DNA replication. San Francisco: Freeman; 1991."},{"key":"4238_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev.bi.59.070190.001445","volume":"59","author":"SW Matson","year":"1990","unstructured":"Matson SW, Kaiser-Rogers KA. DNA helicases. Annu Rev Biochem. 1990;59:289\u2013329.","journal-title":"Annu Rev Biochem"},{"key":"4238_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1146\/annurev.bi.65.070196.001125","volume":"65","author":"TM Lohman","year":"1996","unstructured":"Lohman TM, Bjornson KP. Mechanisms of helicase-catalyzed DNA unwinding. Annu Rev Biochem. 1996;65:169\u2013214.","journal-title":"Annu Rev Biochem"},{"key":"4238_CR5","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0959-440X(05)80116-2","volume":"3","author":"AE Gorbalenya","year":"1993","unstructured":"Gorbalenya AE, Koonin EV. Helicases: amino acid sequence comparisons and structure-function relationships. Curr Opin Struct Biol. 1993;3:419\u201329.","journal-title":"Curr Opin Struct Biol"},{"key":"4238_CR6","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1146\/annurev.biochem.69.1.651","volume":"69","author":"SS Patel","year":"2000","unstructured":"Patel SS, Picha KM. Structure and function of hexameric helicase. Annu Rev Biochem. 2000;69:651\u201397.","journal-title":"Annu Rev Biochem"},{"key":"4238_CR7","doi-asserted-by":"publisher","first-page":"118","DOI":"10.4161\/cib.13844","volume":"4","author":"P Umate","year":"2011","unstructured":"Umate P, Tuteja N, Tuteja R. Genome-wide comprehensive analysis of human helicases. Commun Integr Biol. 2011;4:118\u201337.","journal-title":"Commun Integr Biol"},{"key":"4238_CR8","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1111\/febs.14109","volume":"284","author":"R Tuteja","year":"2017","unstructured":"Tuteja R. Unraveling the importance of the malaria parasite helicases. FEBS J. 2017;284:2592\u2013603.","journal-title":"FEBS J"},{"key":"4238_CR9","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1002\/2211-5463.12728","volume":"9","author":"M Chauhan","year":"2019","unstructured":"Chauhan M, Sourabh S, Yasmin R, Pahuja I, Tuteja R. Biochemical characterization of Plasmodium falciparum parasite-specific helicase 1 (PfPSH1). FEBS Open Bio. 2019;9:1909\u201327.","journal-title":"FEBS Open Bio"},{"key":"4238_CR10","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/s41598-018-38032-1","volume":"9","author":"M Chauhan","year":"2019","unstructured":"Chauhan M, Tuteja R. Plasmodium falciparum specific helicase 2 is a dual, bipolar helicase and is crucial for parasite growth. Sci Rep. 2019;9:1519.","journal-title":"Sci Rep"},{"key":"4238_CR11","doi-asserted-by":"publisher","first-page":"13146","DOI":"10.1038\/s41598-017-12927-x","volume":"7","author":"M Chauhan","year":"2017","unstructured":"Chauhan M, Tarique M, Tuteja R. Plasmodium falciparum specific helicase 3 is nucleocytoplasmic protein and unwinds DNA duplex in 3\u2032 to 5\u2032 direction. Sci Rep. 2017;7:13146.","journal-title":"Sci Rep"},{"key":"4238_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.molbiopara.2014.07.013","volume":"196","author":"P Suntornthiticharoen","year":"2014","unstructured":"Suntornthiticharoen P, Srila W, Chavalitshewinkoon-Petmitr P, Limudomporn P, Yamabhai M. Characterization of recombinant malarial RecQ DNA helicase. Mol Biochem Parasitol. 2014;196:41\u20134.","journal-title":"Mol Biochem Parasitol"},{"key":"4238_CR13","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1186\/s12936-016-1573-2","volume":"15","author":"P Limudomporn","year":"2016","unstructured":"Limudomporn P, Moonsom S, Leartsakulpanich U, Suntornthiticharoen P, Petmitr S, Weinfeld M, et al. Characterization of Plasmodium falciparum ATP-dependent DNA helicase RuvB3. Malar J. 2016;15:526.","journal-title":"Malar J"},{"key":"4238_CR14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1017\/S0031182006000527","volume":"133","author":"P Suntornthiticharoen","year":"2006","unstructured":"Suntornthiticharoen P, Petmitr S, Chavalitshewinkoon-Petmitr P. Purification and characterization of a novel 3\u2032\u20135\u2032 DNA helicase from Plasmodium falciparum and its sensitivity to anthracycline antibiotics. Parasitology. 2006;133:389\u201398.","journal-title":"Parasitology"},{"key":"4238_CR15","doi-asserted-by":"publisher","first-page":"10683","DOI":"10.1016\/S0021-9258(19)50072-2","volume":"267","author":"JW George","year":"1992","unstructured":"George JW, Ghate S, Matson SW, Besterman JM. Inhibition of DNA helicase II unwinding and ATPase activities by DNA-interacting ligands, Kinetics and specificity. J Biol Chem. 1992;267:10683\u20139.","journal-title":"J Biol Chem"},{"key":"4238_CR16","first-page":"993","volume":"41","author":"NR Bachur","year":"1992","unstructured":"Bachur NR, Yu F, Johnson R, Hickey R, Wu Y, Malkas L. Helicase inhibition by anthracycline anticancer agents. Mol Pharmacol. 1992;41:993\u20138.","journal-title":"Mol Pharmacol"},{"key":"4238_CR17","first-page":"1064","volume":"44","author":"NR Bachur","year":"1993","unstructured":"Bachur NR, Johnson R, Yu F, Hickey R, Appelgren N, Malkas L. Antihelicase action of DNA-binding anticancer agents: relationship to guanosine-cytidine intercalator binding. Mol Pharmacol. 1993;44:1064\u20139.","journal-title":"Mol Pharmacol"},{"key":"4238_CR18","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1006\/bbrc.1997.7021","volume":"236","author":"N Tuteja","year":"1997","unstructured":"Tuteja N, Phan TN, Tuteja R, Ochem A, Falaschi A. Inhibition of DNA unwinding and ATPase activities of human DNA helicase II by chemotherapeutic agents. Biochem Biophys Res Commun. 1997;236:636\u201340.","journal-title":"Biochem Biophys Res Commun"},{"key":"4238_CR19","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S0003-9861(03)00176-0","volume":"414","author":"R Tuteja","year":"2003","unstructured":"Tuteja R, Tuteja N, Malhotra P, Singh CV. Replication fork-stimulated eIF-4A from Plasmodium cynomolgi unwinds DNA in the 3\u2032 to 5\u2032 direction and is inhibited by DNA-interacting compounds. Arch Biochem Biophys. 2003;414:108\u201314.","journal-title":"Arch Biochem Biophys"},{"key":"4238_CR20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.gene.2008.05.005","volume":"420","author":"A Pradhan","year":"2008","unstructured":"Pradhan A, Hussain ME, Tuteja R. Characterization of replication fork and phosphorylation stimulated Plasmodium falciparum helicase 45. Gene. 2008;420:66\u201375.","journal-title":"Gene."},{"key":"4238_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4161\/cib.4.3.14778","volume":"4","author":"J Mehta","year":"2011","unstructured":"Mehta J, Tuteja R. Inhibition of unwinding and ATPase activities of Plasmodium falciparum Dbp5\/DDX19 homologue. Commun Integr Biol. 2011;4:1\u20135.","journal-title":"Commun Integr Biol"},{"key":"4238_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00709-014-0664-6","volume":"252","author":"M Ahmad","year":"2015","unstructured":"Ahmad M, Tarique M, Afrin F, Tuteja N, Tuteja R. Identification of inhibitors of Plasmodium falciparum RuvB1 helicase using biochemical assays. Protoplasma. 2015;252:117\u201325.","journal-title":"Protoplasma"},{"key":"4238_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.molbiopara.2011.10.012","volume":"181","author":"M Tarique","year":"2012","unstructured":"Tarique M, Satsangi AT, Ahmad M, Singh S, Tuteja R. Plasmodium falciparum MLH is a schizont stage-specific endonuclease. Mol Biochem Parasitol. 2012;181:153\u201361.","journal-title":"Mol Biochem Parasitol"},{"key":"4238_CR24","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/0035-9203(83)90080-9","volume":"77","author":"S Thaithong","year":"1983","unstructured":"Thaithong S, Beale GH, Chutmongkonkul M. Susceptibility of Plasmodium falciparum to five drugs: an in vitro study of isolates mainly from Thailand. Trans R Soc Trop Med Hyg. 1983;77:228\u201331.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"4238_CR25","first-page":"544","volume":"22","author":"P Chavalitshewinkoon","year":"1991","unstructured":"Chavalitshewinkoon P, Wilairat P. A simple technique for large scale in vitro culture of Plasmodium falciparum. Southeast Asian J Trop Med Public Health. 1991;22:544\u20137.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"4238_CR26","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2307\/3280287","volume":"65","author":"C Lambros","year":"1979","unstructured":"Lambros C, Vanderberg JP. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol. 1979;65:418\u201320.","journal-title":"J Parasitol"},{"key":"4238_CR27","doi-asserted-by":"publisher","first-page":"6785","DOI":"10.1093\/nar\/18.23.6785","volume":"18","author":"N Tuteja","year":"1990","unstructured":"Tuteja N, Tuteja R, Rahman K, Kang LY, Falaschi A. A DNA helicase from human cells. Nucleic Acids Res. 1990;18:6785\u201392.","journal-title":"Nucleic Acids Res"},{"key":"4238_CR28","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1128\/AAC.16.6.710","volume":"16","author":"RE Desjardins","year":"1979","unstructured":"Desjardins RE, Canfield CJ, Haynes JD, Chulay JD. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother. 1979;16:710\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"4238_CR29","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1111\/j.1432-1033.2004.04093.x","volume":"271","author":"N Tuteja","year":"2004","unstructured":"Tuteja N, Tuteja R. Prokaryotic and eukaryotic DNA helicases. Essential molecular motor proteins for cellular machinery. Eur J Biochem. 2004;271:1835\u201348.","journal-title":"Eur J Biochem."},{"key":"4238_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.gene.2012.11.020","volume":"515","author":"M Ahmad","year":"2013","unstructured":"Ahmad M, Tuteja R. Plasmodium falciparum RuvB1 is an active DNA helicase and translocates in the 5\u2032\u20133\u2032 direction. Gene. 2013;515:99\u2013109.","journal-title":"Gene"},{"key":"4238_CR31","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1016\/j.bbapap.2013.10.010","volume":"1834","author":"M Ahmad","year":"2013","unstructured":"Ahmad M, Tuteja R. Plasmodium falciparum RuvB2 translocates in 5\u2032\u20133\u2032 direction, relocalizes during schizont stage, and its enzymatic activities are upregulated by RuvB3 of the same complex. Biochim Biophys Acta. 2013;1834:2795\u2013811.","journal-title":"Biochim Biophys Acta"},{"key":"4238_CR32","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s00709-015-0779-4","volume":"252","author":"L Tajedin","year":"2015","unstructured":"Tajedin L, Tarique M, Tuteja R. Plasmodium falciparum XPD translocates in 5\u2032 to 3\u2032 direction, is expressed throughout the blood stages, and interacts with p44. Protoplasma. 2015;252:1487\u2013504.","journal-title":"Protoplasma"},{"key":"4238_CR33","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1093\/nar\/19.13.3613","volume":"19","author":"N Tuteja","year":"1991","unstructured":"Tuteja N, Rahman K, Tuteja R, Falaschi A. DNA helicase IV from HeLa cells. Nucleic Acids Res. 1991;19:3613\u20138.","journal-title":"Nucleic Acids Res"},{"key":"4238_CR34","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/0076-6879(95)62031-1","volume":"262","author":"SW Matson","year":"1995","unstructured":"Matson SW, Bean DW. Purification and biochemical characterization of enzymes with DNA helicase activity. Methods Enzymol. 1995;262:389\u2013405.","journal-title":"Methods Enzymol"},{"key":"4238_CR35","doi-asserted-by":"publisher","first-page":"17502","DOI":"10.1016\/S0021-9258(18)71522-6","volume":"264","author":"GT Runyon","year":"1989","unstructured":"Runyon GT, Lohman TM. Escherichia coli helicase II (uvrD) protein can completely unwind fully duplex linear and nicked circular DNA. J Biol Chem. 1989;264:17502\u201312.","journal-title":"J Biol Chem"},{"key":"4238_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0167-4781(87)90088-1","volume":"910","author":"H Stahl","year":"1987","unstructured":"Stahl H, Knippers R. The simian virus 40 large tumor antigen. Biochim Biophys Acta. 1987;910:1\u201310.","journal-title":"Biochim Biophys Acta"},{"key":"4238_CR37","doi-asserted-by":"publisher","first-page":"14017","DOI":"10.1016\/S0021-9258(17)44018-X","volume":"258","author":"SW Matson","year":"1983","unstructured":"Matson SW, Tabor S, Richardson CC. The gene 4 protein of bacteriophage T7. Characterization of helicase activity. J Biol Chem. 1983;258:14017\u201324.","journal-title":"J Biol Chem."},{"key":"4238_CR38","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1073\/pnas.86.7.2186","volume":"86","author":"JJ Crute","year":"1989","unstructured":"Crute JJ, Tsurumi T, Zhu LA, Weller SK, Olivo PD, Challberg MD, et al. Herpes simplex virus 1 helicase-primase: a complex of three herpes-encoded gene products. Proc Natl Acad Sci USA. 1989;86:2186\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4238_CR39","doi-asserted-by":"publisher","first-page":"3934","DOI":"10.1093\/nar\/24.20.3934","volume":"24","author":"S Prasartkaew","year":"1996","unstructured":"Prasartkaew S, Zijlstra NM, Wilairat P, Overdulve JP, de Vries E. Molecular cloning of a Plasmodium falciparum gene interrupted by 15 introns encoding a functional primase 53 kDa subunit as demonstrated by expression in a baculovirus system. Nucleic Acids Res. 1996;24:3934\u201341.","journal-title":"Nucleic Acids Res"},{"key":"4238_CR40","doi-asserted-by":"publisher","first-page":"9294","DOI":"10.1021\/bi00491a027","volume":"29","author":"DL Banville","year":"1990","unstructured":"Banville DL, Keniry MA, Shafer RH. NMR investigation of mithramycin A binding to d(ATGCAT)2: a comparative study with chromomycin A3. Biochemistry. 1990;29:9294\u2013304.","journal-title":"Biochemistry"},{"key":"4238_CR41","doi-asserted-by":"publisher","first-page":"6145","DOI":"10.1021\/bi00478a006","volume":"29","author":"JB Chaires","year":"1990","unstructured":"Chaires JB, Herrera JE, Waring MJ. Preferential binding of daunomycin to 5\u2032ATCG and 5\u2032ATGC sequences revealed by footprinting titration experiments. Biochemistry. 1990;29:6145\u201353.","journal-title":"Biochemistry"},{"key":"4238_CR42","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/0014-5793(72)80179-0","volume":"21","author":"P Chandra","year":"1972","unstructured":"Chandra P, Zunino F, Gotz A, Gericke D, Thorbeck R, Di Marco A. Specific inhibition of DNA-polymerases from RNA tumor viruses by some new daunomycin derivatives. FEBS Lett. 1972;21:264\u20138.","journal-title":"FEBS Lett"},{"key":"4238_CR43","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1073\/pnas.71.4.1193","volume":"71","author":"MF Goodman","year":"1974","unstructured":"Goodman MF, Bessman MJ, Bachur NR. Adriamycin and daunorubicin inhibition of mutant T4 DNA polymerases. Proc Natl Acad Sci USA. 1974;71:1193\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4238_CR44","first-page":"126","volume":"341","author":"G Hartmann","year":"1964","unstructured":"Hartmann G, Goller H, Koschel K, Kersten W, Kersten H. Inhibition of DNA-dependent RNA and DNA synthesis by antibiotics. Biochem Z. 1964;341:126\u20138 (in German).","journal-title":"Biochem Z."},{"key":"4238_CR45","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1126\/science.6093249","volume":"226","author":"KM Tewey","year":"1984","unstructured":"Tewey KM, Rowe TC, Yang L, Halligan BD, Liu LF. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science. 1984;226:466\u20138.","journal-title":"Science"},{"key":"4238_CR46","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1042\/bj2790141","volume":"279","author":"G Ciarrocchi","year":"1991","unstructured":"Ciarrocchi G, Lestingi M, Fontana M, Spadari S, Montecucco A. Correlation between anthracycline structure and human DNA ligase inhibition. Biochem J. 1991;279:141\u20136.","journal-title":"Biochem J"},{"key":"4238_CR47","first-page":"2624","volume":"34","author":"YC Lee","year":"1974","unstructured":"Lee YC, Byfield JE, Bennett LR, Chan YM. X-ray repair replication in L1210 leukemia cells. Cancer Res. 1974;34:2624\u201333.","journal-title":"Cancer Res"},{"key":"4238_CR48","first-page":"901","volume":"13","author":"NR Bachur","year":"1977","unstructured":"Bachur NR, Gordon SL, Gee MV. Anthracycline antibiotic augmentation of microsomal electron transport and free radical formation. Mol Pharmacol. 1977;13:901\u201310.","journal-title":"Mol Pharmacol"},{"key":"4238_CR49","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0005-2736(81)90421-1","volume":"649","author":"SA Murphree","year":"1981","unstructured":"Murphree SA, Tritton TR, Smith PL, Sartorelli AC. Adriamycin-induced changes in the surface membrane of sarcoma 180 ascites cells. Biochim Biophys Acta. 1981;649:317\u201324.","journal-title":"Biochim Biophys Acta"},{"key":"4238_CR50","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1021\/mp100269f","volume":"7","author":"P Mohan","year":"2010","unstructured":"Mohan P, Rapoport N. Doxorubicin as a molecular nanotheranostic agent: effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear trafficking. Mol Pharm. 2010;7:1959\u201373.","journal-title":"Mol Pharm"},{"key":"4238_CR51","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.drudis.2016.11.005","volume":"22","author":"M Cagel","year":"2017","unstructured":"Cagel M, Grotz E, Bernabeu E, Moretton MA, Chiappetta DA. Doxorubicin: nanotechnological overviews from bench to bedside. Drug Discov Today. 2017;22:270\u201381.","journal-title":"Drug Discov Today"},{"issue":"12 Suppl 6","key":"4238_CR52","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1212\/WNL.63.12_suppl_6.S15","volume":"63","author":"EJ Fox","year":"2004","unstructured":"Fox EJ. Mechanism of action of mitoxantrone. Neurology. 2004;63(12 Suppl 6):S15\u20138.","journal-title":"Neurology"},{"key":"4238_CR53","first-page":"19","volume":"14","author":"KJ Soderlind","year":"1999","unstructured":"Soderlind KJ, Gorodetsky B, Singh AK, Bachur NR, Miller GG, Lown JW. Bis-benzimidazole anticancer agents: targeting human tumor helicases. Anticancer Drug Des. 1999;14:19\u201336.","journal-title":"Anticancer Drug Des"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-022-04238-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-022-04238-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-022-04238-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T11:10:28Z","timestamp":1657624228000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-022-04238-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,11]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4238"],"URL":"https:\/\/doi.org\/10.1186\/s12936-022-04238-y","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,11]]},"assertion":[{"value":"2 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"216"}}